Who founded Go Therapeutics?

Go Therapeutics was founded by Hans Wandall.

How much funding has Go Therapeutics raised?

Go Therapeutics has disclosed $5M raised across 1 round.

Where is Go Therapeutics headquartered?

Go Therapeutics is headquartered in Cambridge, US.

Go Therapeutics

Cambridge, US · Delaware corporation

Find your way into Go Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Go Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

GO Therapeutics mines the cancer glycoproteome for cancer-specific epitopes and develops high-affinity antibodies used to create ADCs, CAR T cell therapies, and companion diagnostics targeting solid tumors. The company runs in-house and partnered drug discovery programs based on its glycopeptide biology platform.

Biotech Healthtech

Founders & leadership

Hans WandallScientific Co-Founder & Chief Scientific OfficerHans Wandall is an MD and PhD from the University of Copenhagen with postdoctoral training at Harvard Medical School. He has expertise in glycobiology, protein chemistry, and cell biology, and currently serves as Chief Scientific Officer of Go Therapeutics.

Constantine TheodoropulosCo-Founder & Chief Executive Officer

Thayer WhiteNamed on SEC filing

Gregory L. ChaseNamed on SEC filing

Aaron C. GroenDirector of Biology

Reported raises · per SEC filings

Form D private placements

$5M disclosed across 1 round · 2017

▶$5MraisedAug 2017 · 1 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Constantine TheodoropulosExecutive Officer, Director
Thayer WhiteDirector
Gregory L. ChaseDirector

Offering amount: $5M
Amount sold: $5M
First sale: Aug 2017
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 6

Apogee TherapeuticsApogee Therapeutics develops engineered antibody therapies to treat inflammatory and immune diseases with reduced injection frequency compared to existing treatments.

G1 TherapeuticsG1 Therapeutics develops cancer therapies focused on improving patient outcomes and quality of life for people with cancer.

Applied TherapeuticsApplied Therapeutics is a biopharmaceutical company developing novel drugs for rare diseases with high unmet medical need. Its Aldose Reductase Inhibitor franchise is in development across disease areas including Galactosemia and SORD Deficiency.

Kite PharmaKite develops CAR T-cell therapies that engineer a patient's own immune cells to target and destroy cancer cells. The company focuses on cell therapy treatments for cancers such as diffuse large B-cell lymphoma.

Protego BiopharmaProtego Bio is a biotech company developing first-in-class therapies for protein misfolding diseases, including its lead candidate PROT-001 for AL amyloidosis, based on research into pharmacological chaperones. Its work targets patients affected by protein misfolding disorders.

Fate TherapeuticsFate Therapeutics develops investigational cellular immunotherapies to treat autoimmune diseases and cancer. The company is conducting clinical trials on product candidates under strict regulatory and ethical standards.

Companies working in the same space as Go Therapeutics.

Frequently asked questions

What does Go Therapeutics do?: GO Therapeutics mines the cancer glycoproteome for cancer-specific epitopes and develops high-affinity antibodies used to create ADCs, CAR T cell therapies, and companion diagnostics targeting solid tumors. The company runs in-house and partnered drug discovery programs based on its glycopeptide biology platform.
Who founded Go Therapeutics?: Go Therapeutics was founded by Hans Wandall.
How much funding has Go Therapeutics raised?: Go Therapeutics has disclosed $5M raised across 1 round.
Where is Go Therapeutics headquartered?: Go Therapeutics is headquartered in Cambridge, US.